Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia

被引:316
作者
Postma, AV
Denjoy, I
Hoorntje, TM
Lupoglazoff, JM
Da Costa, A
Sebillon, P
Mannens, MMAM
Wilde, AAM
Guicheney, P
机构
[1] Grp Hosp Pitie Salpetriere, INSERM, U523, Inst Myol,IFR Coeur Muscles & Vaisseaux 14, F-75651 Paris 13, France
[2] Univ Amsterdam, Acad Med Ctr, Expt & Mol Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands
[3] Hop Lariboisiere Paris, Serv Cardiol, Paris, France
[4] Antonius Ziekenhuis, Dept Paediat, Nieuwegein, Netherlands
[5] Hop Robert Debre Paris, Serv Cardiol Pediat, Paris, France
[6] Hop Nord St Etienne, Serv Cardiol, St Etienne, France
[7] Grp Hosp Pitie Salpetriere, IFR 14, Assoc Claude Bernard, Lab Genet & Insuffisance Cardiaque, F-75651 Paris 13, France
[8] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands
关键词
calsequestrin; tachycardia; syncope; arrhythmia; genetics;
D O I
10.1161/01.RES.0000038886.18992.6B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare arrhythmogenic disorder characterized by syncopal events and sudden cardiac death at a young age during physical stress or emotion, in the absence of structural heart disease. We report the first nonsense mutations in the cardiac calsequestrin gene, CASQ2, in three CPVT families. The three mutations, a nonsense R33X, a splicing 532+1 G>A, and a 1-bp deletion, 62delA, are thought to induce premature stop codons. Two patients who experienced syncopes before the age of 7 years were homozygous carriers, suggesting a complete absence of calsequestrin 2. One patient was heterozygous for the stop codon and experienced syncopes from the age of 11 years. Despite the different mutations, there is little phenotypic variation of CPVT for the CASQ2 mutations. Of the 16 heterozygous carriers of these various mutations, 14 were devoid of clinical symptoms or ECG anomalies, whereas 2 of them had ventricular arrhythmias at ECG on exercise tests. In line with this, the diagnosis of the probands was difficult because of the absence of a positive family history. In conclusion, these additional three CASQ2 CPVT families suggest that CASQ2 mutations are more common than previously thought and produce a severe form of CPVT. The full text of this article is available at http://www.circresaha.org.
引用
收藏
页码:E21 / E26
页数:6
相关论文
共 17 条
  • [1] Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death early diagnosis of asymptomatic carriers - Early diagnosis of asymptomatic carriers
    Bauce, B
    Rampazzo, A
    Basso, C
    Bagattin, A
    Daliento, L
    Tiso, N
    Turrini, P
    Thiene, G
    Danieli, GA
    Nava, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (02) : 341 - 349
  • [2] Nonsense-mediated mRNA decay in health and disease
    Frischmeyer, PA
    Dietz, HC
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (10) : 1893 - 1900
  • [3] HALL GW, 1994, BLOOD, V83, P2031
  • [4] A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel
    Lahat, H
    Pras, E
    Olender, T
    Avidan, N
    Ben-Asher, E
    Man, O
    Levy-Nissenbaum, E
    Khoury, A
    Lorber, A
    Goldman, B
    Lancet, D
    Eldar, M
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (06) : 1378 - 1384
  • [5] Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia
    Laitinen, PJ
    Brown, KM
    Piippo, K
    Swam, H
    Devaney, JM
    Brahmbhatt, B
    Donarum, EA
    Marino, M
    Tiso, N
    Viitasalo, M
    Toivonen, L
    Stephan, DA
    Kontula, K
    [J]. CIRCULATION, 2001, 103 (04) : 485 - 490
  • [6] LEBERER E, 1990, J BIOL CHEM, V265, P10118
  • [7] CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR-TACHYCARDIA IN CHILDREN - A 7-YEAR FOLLOW-UP OF 21 PATIENTS
    LEENHARDT, A
    LUCET, V
    DENJOY, I
    GRAU, F
    DONGOC, D
    COUMEL, P
    [J]. CIRCULATION, 1995, 91 (05) : 1512 - 1519
  • [8] Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death
    Marks, AR
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (04) : 615 - 624
  • [9] Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia
    Priori, SG
    Napolitano, C
    Memmi, M
    Colombi, B
    Drago, F
    Gasparini, M
    DeSimone, L
    Coltorti, F
    Bloise, R
    Keegan, R
    Cruz, FES
    Vignati, G
    Benatar, A
    DeLogu, A
    [J]. CIRCULATION, 2002, 106 (01) : 69 - 74
  • [10] Priori SG, 2001, CIRCULATION, V103, P196